Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies

Detection Principle
IgM, IgG, IgA and total Ab
Testing Method
ELISA kits
Testing Method - Additional Info
The NovaLisa SARS?CoV?2 IgG, IgA, IgM test (NovaTec) and the Platelia SARS?CoV?2 Total Ab test (Bio?Rad)
Reported Performance
sensitivity: 94.9% (NovaLisa, IgG), 89.7% (NovaLisa, IgA), 48.7% (NovaLisa, IgM), 94.9% (Platelia, total Ab); specificity: 96.2% (NovaLisa, IgG), 98.7% (NovaLisa, IgA), 98.7% (NovaLisa, IgM), 97.4% (Platelia, total Ab)
Sample Size
208 samples

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements